Jazz Pharmaceuticals's total assets for Q1 2025 were $11.53B, a decrease of -3.98% from the previous quarter. JAZZ total liabilities were $7.36B for the fiscal quarter, a -7.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.